TABLE 5.16 Arthralgia

Study

Design

Population

Outcomes

Results

Adjustments

Comments or Limitations

Eisen et al. 2005

Population-based, cross-sectional, prevalence, medical evaluation

1,061 deployed vs 1,128 nondeployed

Persistent and clinically significant bone or joint symptoms with or without joint effusion, and treatment with anti-inflammatory agents, narcotic pain medications, ornonnarcotic pain medications

Prevalence: 6.4% vs. 6.8%, OR 1.15 (95% CI 0.70-1.89)

Age, sex, race, yearsof education, cigarette-smoking, duty type, service branch, rank

Low participation rates, especially among nondeployed



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement